AMARIN CORP PLC\UK Prepaid Expense and Other Assets, Current
AMARIN CORP PLC\UK (AMRN) had Prepaid Expense and Other Assets, Current of $30.92 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-07-29
- 2026-06-30: Prepaid Expense and Other Assets, Current $30.92M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $26.36M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $24.35M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $29.43M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $30.92M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $26.36M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $24.35M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $29.43M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $17.44M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $24.75M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $12.55M 10-K · filed 2026-03-02 |
| 2024-09-30 | $7.32M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $31.55M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $8.14M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $11.62M 10-K · filed 2025-03-12 |
| 2023-09-30 | $19.46M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $43.31M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $19.88M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $19.49M 10-K · filed 2024-02-29 |
| 2022-09-30 | $27.91M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $32.26M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $28.09M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $22.35M 10-K · filed 2023-03-01 |
| 2021-09-30 | $21.34M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $28.43M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $29.70M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $30.95M 10-K · filed 2022-03-01 |
| 2020-09-30 | $26.95M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $23.59M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $20.76M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $13.31M 10-K · filed 2021-02-25 |
| 2019-09-30 | $12.86M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $7.10M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $5.33M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $2.94M 10-K · filed 2020-02-25 |
| 2018-09-30 | $2.94M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $2.88M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $3.62M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $3.46M 10-K · filed 2019-02-27 |
| 2017-09-30 | $4.18M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $2.08M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $4.79M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $6.98M 10-K · filed 2018-02-27 |
| 2016-09-30 | $5.74M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $5.48M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $6.11M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.15M 10-K · filed 2017-03-01 |
| 2015-09-30 | $4.69M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $1.31M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $2.29M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $2.63M 10-K · filed 2016-02-25 |
| 2011-12-31 | $1.84M 10-K · filed 2012-02-29 |
| 2010-12-31 | $712.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |